Refreshing results…
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc 1
UploadShort-course combination treatment for experimental chronic Chagas disease
UploadLysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs
Download from doi.orgMymA Bioactivated Thioalkylbenzoxazole Prodrug Family Active against Mycobacterium tuberculosis
Download from pubs.acs.orgDiagnóstico molecular del retinoblastoma: epidemiología molecular y consejo genético
Download from digital.csic.esMissing publications? Search for publications with a matching author name.